Professional Documents
Culture Documents
http://www.kidney-international.org
& 2009 International Society of Nephrology
Department of Clinical Epidemiology, Leiden University Medical Centre, Leiden, The Netherlands; 2ERAEDTA Registry, Department of
Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands and 3CNRIBIM, Clinical
Epidemiology and Pathophysiology of Renal Diseases and Hypertension, Renal and Transplantation Unit, Ospedali Riunti, Reggio
Calabria, Italy
abc of epidemiology
R de Mutsert et al.: The effect of joint exposures: examining the presence of interaction
52.7/1000 py, 52.716.9 35.8/1000 py more due to exposure to CVD. When no interaction between CKD and CVD
would be present, we would expect an outcome rate in
persons exposed to both CKD and CVD at baseline of
16.9 28 35.8 80.7/1000 py: 16.9/1000 py will get the
outcome anyway, an extra 28/1000 py due to exposure to
CKD and an additional 35.8/1000 py due to exposure to
CVD. The observed rate, however, was 116.4/1000 py.9 Thus,
the composite outcome occurred in 116.480.7 35.7
persons per 1000 py more than we would expect on the
basis of the sum of the separate effects of CVD and CKD,
implying the presence of causal interaction between CKD and
CVD. In other words, due to interaction between CKD and
CVD, an excess risk of 35.7/1000 py has been observed.
Although some consider every single extra case a departure
from additivity, the clinical relevance of the magnitude of the
effect needs of course to be evaluated on the basis of
knowledge on the subject matter. Note that in this first
example, we evaluated the presence of interaction on the
basis of risk differences on an additive scale (the calculation
of risk differences was reported in an earlier paper of this
series10).
STATISTICAL INTERACTION
CVD
CVD+
CKD
CKD+
16.9
52.7
44.9
116.4
678
abc of epidemiology
140
8.28
120
6.89
100
4.78
80
60
3.12
2.66
40
20
ln p=1 p b0 b1 X 1 b2 X 2 b3 X 1 X 2
This equation can be rewritten as
b0 b1 X1 b2 X2 b3 X1 X2
p=1 p e
Reference
b0
e e
b1 X 1
b2 X 2
e
e
b3 X1 X2
Relative risk
Rate/1000 person-years
R de Mutsert et al.: The effect of joint exposures: examining the presence of interaction
CKD
CVD
CKD + CVD
abc of epidemiology
R de Mutsert et al.: The effect of joint exposures: examining the presence of interaction
The Dialysis Clinical Outcomes Revisited trial is a randomized trial of sevelamer compared to calcium-based phosphate
binders in 1068 prevalent hemodialysis patients.20 A
significant interaction effect between age and treatment
(P 0.02) was detected in relation to all-cause mortality and
hazard ratios were reported separately for younger patients
(o65 years) (HR:1.18, 95% CI: 0.911.53) and older patients
(X65 years) (HR:0.77, 95% CI: 0.610.96).
With these results only, the presence of interaction cannot
be interpreted on an additive scale. Because the mortality
rates of each exposure group were also reported we are,
however, able to interpret the interaction effect on an additive
level. The mortality rate in younger patients on calciumcontaining binders was 10.6 per 100 patient-year, 12.5/100 py
in younger patients on sevelamer, and 23.4/100 py in older
patients on calcium-containing binders.20 On the basis of the
Kidney International (2009) 75, 677681
R de Mutsert et al.: The effect of joint exposures: examining the presence of interaction
abc of epidemiology
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
681